GENB
Generate Biomedicines, Inc.
Key Financials
Net Income
$-61446000
N/A
Operating Income
$-64112000
N/A
Revenue
$7.2M
N/A
EPS (Diluted)
$-1.07
N/A
Total Liabilities
$110.9M
N/A
Total Assets
$625.7M
N/A
Shareholders' Equity
$514.8M
N/A
Operating Cash Flow
$-80388000.00
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 3 | 3/12/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GENB |
| Company Name | Generate Biomedicines, Inc. |
| CIK | 2100782 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 888-469-0055 |